CAS: 883986-34-3

AZD2932

AZD2932 is a potent and multi-targeted kinase inhibitor VEGFR2, PDGFβ, Flt-3, and c-Kit.

AZD2932 is a small molecule that is an inhibitor of the CXCR4 receptor and has been shown to inhibit the proliferation of various types of cancer cells. The compound binds to the receptor and blocks its function, which may lead to the death of cancer cells. AZD2932 has also been shown to reduce inflammation in mice with inflammatory diseases, such as arthritis. This drug has not been tested in humans, but it has been shown to be effective against hepg2 cells and lung fibroblasts in cell culture studies. AZD2932 was found to be an effective dose for inhibiting adp-ribose production, which is a key regulator of endothelial cell proliferation. AZD2932 also appears to have structural biology interactions with monoclonal antibodies that could lead to new therapeutic treatments for cancer and other diseases.